普适泰联合抗生素治疗慢性前列腺炎的Meta分析  

A Meta-analysis on Prostat Combined with Antibiotic for Chronic Prostatitis

作　　者：严凤花 严兴科[1] 何天有[1] 姚旭红 

机构地区：[1]甘肃中医学院针灸推拿学院,兰州730000

出　　处：《华西医学》2014年第8期1512-1517,共6页West China Medical Journal

基　　金：国家自然科学基金(81060304)~~

摘　　要：目的评价普适泰联合抗生素治疗慢性前列腺炎的疗效及安全性。方法应用计算机检索2003年1月-2013年8月间发表在中国知网数据库、万方数据库、中国生物医学文献数据库、维普数据库、Pubmed数据库的相关文献,并结合手工检索相关文献的参考文献,纳入普适泰联合抗生素治疗慢性前列腺炎的临床随机对照试验（RCT）,对纳入文献依据Jadad量表进行质量评价及数据提取,并用RevMan 5.1软件进行Meta分析。结果共纳入12篇相关研究的RCT文献,共3 947例患者。其中1篇文献采用双盲,3篇文献应用单盲。Jadad评分除1篇文献为3分,属高质量文献外,其余均为1～2分的低质量文献。Meta分析结果显示：普适泰联合加替沙星治疗慢性前列腺炎与单纯应用加替沙星比较,总有效率差异有统计学意义[OR=3.98,95%CI（2.67,5.94）,P〈0.000 01],美国国立卫生研究所慢性前列腺炎症状积分（NIH-CPSI）差异有统计学意义[WMD=-6.45,95%CI（-7.55,-5.34）,P〈0.000 01];普适泰联合左氧氟沙星治疗慢性前列腺炎与仅用左氧氟沙星比较,总有效率差异有统计学意义[OR=1.71,95%CI（1.43,2.05）,P〈0.000 01],NIH-CPSI总评分差异有统计学意义[WMD=-2.85,95%CI（-3.39,-2.31）,P〈0.000 01]。结论普适泰联合抗生素治疗慢性前列腺炎较单纯应用抗生素或普适泰有较好的临床疗效,但其临床应用的安全性仍需在今后进一步评价。Objective To evaluate the efficacy and safety of prostat in combination with antibiotic on the treatment of chronic proatatitis. Methods We searched the literatures which were randomized controlled trials（RCT） on the treatment of combination of prostat and antibiotic for chronic prostatitis published between January 2003 and August 2013 in the Databases including CNKI, Wanfang database, VIP, CBM, PubMed, according to the demand of Cochrane Colloboration, combining computer retrieval with manual retrieval. The quality of literature was assessed by using Jadad scale and extract data from literature. Meta-analyses were performed by using the RevMan 5.1 Software. Results A total of 12 clinical RCT, involving 3 947 patients were identified. One study was double-blind and three studies were single-blind. Only one study had a Jadad scale score of 3, belonging to high quality document; the rest had a score of 2 or 1, and all were low quality documents. The results of the Meta-analysis showed that compared with the control groups, the treatment of combination of prostat with gatifloxacin on chronic prostatitis had a significant difference in total effective rate [OR=3.98, 95%CI（2.67, 5.94）, P〈0.000 01], NIHCPSI score [WMD=-6.45, 95%CI（-7.55,-5.34）, P〈0.000 01]; the treatment of combination of prostat with Levofloxacin on chronic prostatitis had a significant difference in total effective rate [OR=1.71, 95%CI（1.43, 2.05）, P〈0.000 01], NIHCPSI score [WMD=-2.85, 95%CI（-3.39,-2.31）, P〈0.000 01]. Conclusions The treatment of combination of prostat with antibiotic was superior to the treatment of prostat or antibiotics on chronic prostatitis. It is an effective therapeutic schedule. But the safety of the treatment of combination of prostat and antibiotic on chronic prostatitis needs further evaluation.

关 键 词：慢性前列腺炎 普适泰 抗生素 随机对照试验 META分析 

分 类 号：R697.3[医药卫生—泌尿科学]